Scarica l'app Stockscreener
1.38
0.00%
0.00
Pre-mercato:
1.38
Precedente Chiudi:
$1.38
Aprire:
$1.38
Volume 24 ore:
873.33K
Relative Volume:
0.15
Capitalizzazione di mercato:
$134.62M
Reddito:
$1.20M
Utile/perdita netta:
$-52.41M
Rapporto P/E:
-1.5165
EPS:
-0.91
Flusso di cassa netto:
$-31.25M
1 W Prestazione:
+1.47%
1M Prestazione:
-1.43%
6M Prestazione:
+159.40%
1 anno Prestazione:
-3.50%
Intervallo 1D:
$1.36
$1.40
Intervallo di 1 settimana:
$1.31
$1.435
Portata 52W:
$0.387
$3.87
Rani Therapeutics Holdings Inc Stock (RANI) Company Profile
Nome
Rani Therapeutics Holdings Inc
Settore
Industria
Telefono
(408) 457-3700
Indirizzo
2051 RINGWOOD AVENUE, SAN JOSE
Confronta RANI con altri titoli
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
RANI
Rani Therapeutics Holdings Inc
|
1.38 | 134.62M | 1.20M | -52.41M | -31.25M | -0.91 |
|
VRTX
Vertex Pharmaceuticals Inc
|
474.17 | 120.98B | 11.74B | 3.68B | 3.34B | 14.19 |
|
REGN
Regeneron Pharmaceuticals Inc
|
771.25 | 80.15B | 14.25B | 4.58B | 3.88B | 41.77 |
|
ARGX
Argen X Se Adr
|
864.42 | 51.56B | 3.06B | 1.28B | 447.35M | 19.67 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
354.75 | 47.74B | 3.21B | 43.57M | 221.36M | 0.2405 |
|
ONC
Beone Medicines Ltd Adr
|
336.16 | 37.38B | 4.98B | 69.59M | 525.67M | 0.5197 |
Rani Therapeutics Holdings Inc Stock (RANI) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2024-08-02 | Iniziato | Oppenheimer | Outperform |
| 2024-06-14 | Iniziato | Maxim Group | Buy |
| 2024-06-13 | Iniziato | Rodman & Renshaw | Buy |
| 2023-04-17 | Ripresa | BTIG Research | Buy |
| 2022-10-11 | Iniziato | UBS | Buy |
| 2022-07-27 | Iniziato | H.C. Wainwright | Buy |
| 2022-06-13 | Iniziato | Wedbush | Outperform |
Mostra tutto
Rani Therapeutics Holdings Inc Borsa (RANI) Ultime notizie
Bear Alert: Does CompoSecure Inc Equity Warrant stock have upside surprise potential2025 Sector Review & Daily Stock Trend Watchlist - baoquankhu1.vn
Published on: 2026-01-24 03:15:13 - baoquankhu1.vn
AI Stocks: Does XBiotech Inc offer margin of safety2025 Macro Impact & Short-Term High Return Ideas - baoquankhu1.vn
Retail investors account for 65% of Rani Therapeutics Holdings, Inc.'s (NASDAQ:RANI) ownership, while private equity firms account for 17% - Yahoo Finance
Analysts Offer Insights on Healthcare Companies: Rani Therapeutics Holdings (RANI), Ardelyx (ARDX) and AxoGen (AXGN) - The Globe and Mail
Rani Therapeutics finalizes governance and capital structure changes - MSN
Targets Report: Can Rani Therapeutics Holdings Inc navigate macro headwindsJuly 2025 Chart Watch & Consistent Return Investment Signals - baoquankhu1.vn
Price Action: Can Rani Therapeutics Holdings Inc navigate macro headwinds2025 Technical Patterns & Community Supported Trade Ideas - baoquankhu1.vn
HOKA Shoe Comparison: Will Rani Therapeutics Holdings Inc. stock outperform tech sector in 2025Grip and Outsole Review & quick comparison of popular models - Улправда
HC Wainwright Reaffirms Buy Rating for Rani Therapeutics (NASDAQ:RANI) - MarketBeat
RANI: HC Wainwright Reiterates Buy Rating with $11 Target | RANI Stock News - GuruFocus
Is Rani Therapeutics Holdings Inc. stock positioned well for digital economyJuly 2025 Summary & Consistent Return Investment Signals - Улправда
How Rani Therapeutics Holdings Inc. stock reacts to inflationary pressuresTrade Risk Report & Long-Term Investment Growth Plans - Улправда
How Rani Therapeutics Holdings Inc. stock compares to growth peersJuly 2025 Chart Watch & Verified Momentum Stock Watchlist - Улправда
Can Rani Therapeutics Holdings Inc. stock sustain revenue growthQuarterly Profit Report & Verified Momentum Stock Alerts - Улправда
Can Rani Therapeutics Holdings Inc. stock hit record highs againQuarterly Profit Review & Growth Focused Entry Point Reports - Улправда
Aug Intraday: Is Rani Therapeutics Holdings Inc. stock positioned well for digital economyJuly 2025 Volume & Scalable Portfolio Growth Methods - Улправда
Rani Therapeutics begins phase 1 trial of oral obesity treatment By Investing.com - Investing.com Australia
Rani Therapeutics Initiates Phase 1 Study of RT-114 RaniPill® for the Treatment of Obesity in Collaboration with ProGen - The Manila Times
Rani Therapeutics begins phase 1 trial of oral obesity treatment - Investing.com
Rani Therapeutics Initiates Phase 1 Study of RT-114 - GlobeNewswire
Can Rani Therapeutics Holdings Inc. stock rebound after recent weaknessMorning Star Patterns & Invest Now - Улправда
Rani Therapeutics Holdings, Inc. (NASDAQ:RANI) Given Average Recommendation of "Moderate Buy" by Brokerages - MarketBeat
Rani Therapeutics amends charter, reduces Class B voting power and ends tax agreement - Investing.com Nigeria
Rani Therapeutics (NASDAQ:RANI) Stock Price Down 2.2%What's Next? - MarketBeat
Analyst Upgrade: Will Rani Therapeutics Holdings Inc. stock outperform tech sector in 2025Quarterly Market Summary & Proven Capital Preservation Tips - moha.gov.vn
Verrica Pharmaceuticals (VRCA) Stock Price, Quote, News & History - Benzinga
Rani Therapeutics Holdings, Inc.(NasdaqGM: RANI) added to NASDAQ Biotechnology Index - marketscreener.com
Will Rani Therapeutics Holdings Inc. stock outperform tech sector in 2025Market Activity Recap & AI Based Buy/Sell Signal Reports - Улправда
Can Rani Therapeutics Holdings Inc. stock beat market expectations this quarterForecast Cut & Short-Term High Return Ideas - Улправда
Is Rani Therapeutics Holdings Inc. stock attractive after correctionJuly 2025 Sentiment & Stock Portfolio Risk Control - DonanımHaber
What Wall Street predicts for Rani Therapeutics Holdings Inc. stock price2025 Fundamental Recap & Reliable Breakout Forecasts - DonanımHaber
Rani Therapeutics Holdings, Inc. (NASDAQ:RANI) Receives Consensus Rating of "Moderate Buy" from Analysts - MarketBeat
Rani Therapeutics (NASDAQ:RANI) Stock Price Up 1.3%Here's Why - MarketBeat
Rani Therapeutics (RANI) outlines $60.3M financing, 125M-share warrants and new governance terms - Stock Titan
RANI Stock Today, 28 November 2025: Price Action, Options Expiry and Outlook After the $1 Billion Chugai Deal - ts2.tech
Block Trades: Can Rani Therapeutics Holdings Inc. stock beat market expectations this quarterTrade Signal Summary & Weekly Momentum Picks - Bộ Nội Vụ
Rani Therapeutics to Participate in the Evercore Healthcare Conference - The Manila Times
Why Is Rani Therapeutics’ Stock Skyrocketing Pre-Market Today? - MSN
Rani Therapeutics Holdings Inc Azioni (RANI) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
2.09%
0.48%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):